Temokapril

Temokapril
(IUPAC) ime
[(2S)-6[(1S)-1-(etoksikarbonil)-3-fenilpropil]amino5-okso-2-(2-tienil)-1,4-tiazepan-4-il]sirćetna kiselina
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 111902-57-9
ATC kod C09AA14
PubChem[1][2] 71323
UNII 18IZ008EU6 DaY
KEGG[3] D08566 DaY
Hemijski podaci
Formula C23H28N2O5S2 
Mol. masa 476,608 g/mol
SMILES eMolekuli & PubHem
InChI
InChI=1S/C23H28N2O5S2/c1-2-30-23(29)17(11-10-16-7-4-3-5-8-16)24-18-15-32-20(19-9-6-12-31-19)13-25(22(18)28)14-21(26)27/h3-9,12,17-18,20,24H,2,10-11,13-15H2,1H3,(H,26,27)/t17-,18?,20-/m0/s1
Key: FIQOFIRCTOWDOW-DXCJPMOASA-N DaY
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Temokapril (Temokaprilum, Acecol) je ACE inhibitor.[4] On nije odobren za upotrebu u SAD.

Osobine

Osobina Vrednost
Broj akceptora vodonika 7
Broj donora vodonika 2
Broj rotacionih veza 11
Particioni koeficijent[5] (ALogP) 0,8
Rastvorljivost[6] (logS, log(mol/L)) -5,6
Polarna površina[7] (PSA, Å2) 149,5

Reference

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  4. Hisao Oguchi1, Masuo Tokoo, Shinichi Tokunaga, Makoto Higuchi, Kazuhiko Hora, Seiichi Furuta (1995). Temocapril, A Novel Angiotensin-Converting Enzyme Inhibitor with Preferential Biliary Excretion. 13. pp. 66–85. DOI:10.1111/j.1527-3466.1995.tb00214.x. 
  5. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  6. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  7. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

  • Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7. 
  • Thomas L. Lemke, David A. Williams, ur. (2007). Foye's Principles of Medicinal Chemistry (6 izd.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9. 

Spoljašnje veze

Portal Medicina
Portal Hemija
Temokapril na Wikimedijinoj ostavi
  • Temocapril
  • p
  • r
  • u
Antihipertenzivi: Lekovi koji deluju na renin-angiotenzin sistem (C09)
AKE inhibitori/
("-pril")AIIRAi/
("-sartan")Renin inhibitori/
("-kiren")

M: VAS

anat (a:h/u/t/a/l,v:h/u/t/a/l)/phys/devp/cell/prot

vabo/siva/kong/tumr, sizn/epon

proc, lek (C2s+n/3/4/5/7/8/9)